<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01167803</url>
  </required_header>
  <id_info>
    <org_study_id>PHRC-I/2009/EN-01</org_study_id>
    <secondary_id>2009-017126-39</secondary_id>
    <nct_id>NCT01167803</nct_id>
  </id_info>
  <brief_title>Anesthesia for Obese Patients: Desflurane Versus Xenon</brief_title>
  <acronym>XENON</acronym>
  <official_title>Coming Out of Anesthesia After Bariatric Surgery : Desflurane Versus Xenon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is increasing in France, resulting in an increased demand for bariatric surgery.
      However obesity also alters physiopathological pathways and the pharmacokinetics of
      anesthestic agents. The investigators objective is to compare, among morbidly obese patients,
      the immediate and intermediary emergence kinetics after balanced anesthesia using
      remifentanil associated either with desflurane (reference arm) or with xenon (experimental
      arm).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30 min DSST ratio</measure>
    <time_frame>30 minutes post-op</time_frame>
    <description>(the number of correct responses to a Digit Symbol Substitution Test [DSST] 30 minutes after surgery) / (the number of correct responses to a Digit Symbol Substitution Test the night before the surgery)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>60 min DSST test</measure>
    <time_frame>60 minutes post-op</time_frame>
    <description>(the number of correct responses to a Digit Symbol Substitution Test 60 minutes after surgery) / (the number of correct responses to a Digit Symbol Substitution Test the night before the surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 min DSST test</measure>
    <time_frame>90 min post-op</time_frame>
    <description>(the number of correct responses to a Digit Symbol Substitution Test 90 minutes after surgery) / (the number of correct responses to a Digit Symbol Substitution Test the night before the surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Aldrete score of 10</measure>
    <time_frame>Immediate post-op; this outcome measures the minutes of emergence (from anesthesia) time necessary to attain an Aldrete score of 10</time_frame>
    <description>Aldrete JA. The post-anesthesia recovery score revisited. J. Clin. Anesth. 1995.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery score</measure>
    <time_frame>Day 1 post-op</time_frame>
    <description>The score on the Quality of Recovery Scale:
Myles PS, Weitkamp B, Jones K et al. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br. J. Anaesth., 2000; 84: 11-15.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">192</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Reference - desflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients in this group will undergo anesthesia using remifentanil associated with desflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental - xenon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients in this group will undergo anesthesia using remifentanil associated with xenon</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Patients undergo anesthesia using remifentanil associated with desflurane</description>
    <arm_group_label>Reference - desflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xenon</intervention_name>
    <description>Patients undergo anesthesia using remifentanil associated with xenon</description>
    <arm_group_label>Experimental - xenon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) I to III

          -  requires bariatric surgery

          -  body mass index (BMI) &gt;= 35 kg/m2

          -  patient speaks and writes French

          -  patient has signed consent form

          -  patient enrolled in a social security program

        Exclusion Criteria:

          -  patient refuses to sign consent

          -  ASA IV or more

          -  patient is pregnant or breastfeeding

          -  history of hyperthermy (or suspicion, or family history thereof)

          -  history of liver disease, icterus, unexplained fever, or eosinophilia after
             administration of a halogen anesthesia

          -  patient has symptomatic gastro-oesophagean reflux

          -  patient has hypersensitivity to one or more of the following substances: propofol,
             remifentanil, celocurine, cisatracurium, rocuronium, desflurane, xenon, paracetamol,
             ketoprofen, nefopam, tramadol

          -  patient has obstructive respiratory failure (chronic obstruction pneumopathy, asthma)
             or has heart disease with severly altered cardiac function

          -  patient has high intracranial pressure

          -  patient requires high concentrations of oxygen (fio2&gt;40%)

          -  patient has a neuro-sensorial deficient which prevents reading, writing, or response
             to simple oral commands (severe deafness, language impairment...)in the absence of a
             prothesis

          -  patient has a psychiatric pathology, or chronically consumes alcohol or other
             mind-altering substance

          -  patient has had general anesthesia in the last 15 days

          -  patient under guardianship

          -  impossible to correctly communicate information to the patient

          -  absence of efficient contraception for women of childbearing age

          -  participation in another study within the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Ripart, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Clermont Ferrand - Hôpital Estaing</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille - Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Montpellier - Hôpital Saint-Eloi</name>
      <address>
        <city>Montpellier Cedex 5</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpitaux L'Archet 1 et 2</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers Cedex</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2010</study_first_submitted>
  <study_first_submitted_qc>July 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2010</study_first_posted>
  <last_update_submitted>March 26, 2015</last_update_submitted>
  <last_update_submitted_qc>March 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bariatric surgery</keyword>
  <keyword>Anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

